Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press activity in Media Coverage, and Taconic's commitment to being Models For Life™.

A Proper Welcome: How to Care for Humanized Mice

A Proper Welcome: How to Care for Humanized Mice

Taconic Biosciences' Dr. Megan MacBride penned this article for AALAS to discuss how to properly care for humanized mice such as allowing time to acclimate, limit handling, among other suggestions worth heeding: "When lab mice are received at a research facility, investigators typically are eager to enroll them in a study as soon as possible. That's understandable, given the pressure to speed drug discovery and accelerate time-to-market...  Read More

Taconic Biosciences is First and Only Animal Vendor to Announce All Commercial Mouse Colonies Free of New Pathogen

Taconic Biosciences is First and Only Animal Vendor to Announce All Commercial Mouse Colonies Free of New Pathogen

Rensselaer, NY — June 3, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces that all commercial mouse colonies and contract mouse breeding barriers are free of a newly discovered pathogen. Taconic is the first and only commercial animal vendor to exclude mouse kidney parvovirus from its animals at all health standards. In an October 2018 Cell paper, an Australian and...  Read More

Cancer and the Microbiome

Cancer and the Microbiome

In an article recently published in The Translational Scientist, Taconic's Dr. Alexander Maue and Dr. Ivan Gladwyn-Ng review the role of the microbiome and development and treatment of cancer. While most early studies involving the microbiome focused on diseases relating to the gastrointestinal tract, researchers are beginning to study how microbiome composition impacts tumor development and whether a given therapeutic is effective. Specifically, the microbiome has been...  Read More

The cure for going alone: How M&A will drive oncology research in 2019

The cure for going alone: How M&A will drive oncology research in 2019

In a recent article published in Drug Discovery World, Taconic Biosciences's Dr. Michael Seiler explains how there have been multiple mergers and acquisitions of key biotech and pharma companies in the last five years. One specific area that has seen major growth is in the field of immunotherapy drugs — drugs that use a patient's immune system to fight cancer. Of note would be the acquisition of...  Read More

Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles

Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles

Rensselaer, NY — April 15, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOME™, a first of its kind solution enabling the generation and maintenance of mice with custom microbiome profiles. TruBIOME™ was developed to meet the research community's need for a microbiome solution that affords increased predictability, reproducibility, and systems biology insight within mouse model use....  Read More

The changing landscape for licensing lab mice

The changing landscape for licensing lab mice

An article recently published in the journal Lab Animal highlights the intellectual property (IP) associated with the creation of new, genetically engineered mouse models. Taconic Biosciences' Dr. Megan MacBride has witnessed the development of new models and the IP associated with each firsthand. When creating a specialized mouse for Roland Wolf, professor of pharmacology at the University of Dundee, Taconic had to obtain all the necessary patents...  Read More

CRISPR Jump-Starts Gene Therapy

CRISPR Jump-Starts Gene Therapy

In a recent article published in Genetic Engineering News, the CRISPR technology is highlighted as a tool for clinical gene therapy in humans. In February of this year, the first patient was dosed with a CRISPR-Cas9 therapeutic in a Phase I/II trial for treatment of β-thalassemia (a type of inherited blood disorder). However, before CRISPR can become a broad-spectrum treatment for all genetic disorders, tests in animal...  Read More

Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases

Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases

Rensselaer, NY — April 1, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild Mouse gut microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). Investigators at the NIDDK studied wild mice gut microbiota, finding it differs dramatically from that of...  Read More

Animal Health Standards: Why Careful Selection and Harmonization Are Musts

Animal Health Standards: Why Careful Selection and Harmonization Are Musts

A recent article published in LaboratoryEquipment.com features Taconic Biosciences's Product Manager Jennifer Phelan and the topic of lab animal health standards. "Fifty years ago, the chief concern about a lab animal's health was the presence of infectious disease," writes Phelan. She continues to state that current concerns for lab animal health are instead focused on defining health standards for barriers and keeping these standards consistent across all...  Read More

Rodents in Space Will Show How Genes Are Affected by Microgravity

Rodents in Space Will Show How Genes Are Affected by Microgravity

An article published this month in Seeker.com highlights the most recent Rodent Research space mission which launched to the International Space Station on December 5th, 2018 carrying 40 BALB/cAnNTac mice from Taconic Biosciences. The study had three specific aims: To evaluate muscle atrophy under microgravity conditions To quantify changes in tissue-specific molecular markers and To characterize the effects of microgravity on bone density during and after the...  Read More